Matrix metalloproteinase inhibitors in cancer: an update
Marshall, J.L.; Baidas, S.; Bhargava, P.; Rizvi, N.
Idrugs the Investigational Drugs Journal 3(5): 518-524
2000
ISSN/ISBN: 1369-7056 PMID: 16100684 Document Number: 512355
Document emailed within 1 workday
Related Documents
Guo, L.-j.; Luo, X.-h.; Xie, H.; Zhou, H.-d.; Liao, E.-y. 2005: The effects of 1alpha,25-dihydroxyvitamin D3 in regulation matrix metalloproteinase and tissue metalloproteinase inhibitors in human osteoblasts Zhonghua Nei Ke Za Zhi 44(2): 125-128Tsai, H-Chin.; Chung, L-Yu.; Chen, E-Rin.; Liu, Y-Ching.; Lee, S.Shin-Jung.; Chen, Y-Shen.; Sy, C-Len.; Wann, S-Ren.; Yen, C-Min. 2008: Association of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-4 in cerebrospinal fluid with blood-brain barrier dysfunction in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis American Journal of Tropical Medicine and Hygiene 78(1): 20-27
Yoshikawa, T.; Suzuki, K.; Kobayashi, O.; Sairenji, M.; Motohashi, H.; Yanoma, S.; Noguchi, Y.; Tsuburaya, A. 1998: Clinical significance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in peripheral blood of patients with gastric carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(9): 1461-1464
Mafune, K. 2001: Matrix metalloproteinase (MMP), matrix serine proteinase (MSP), tissue inhibitor of metalloproteinase (TIMP) Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 176-183
Michaelides, M.R.; Curtin, M.L. 1999: Recent advances in matrix metalloproteinase inhibitors research Current Pharmaceutical Design 5(10): 787-819
Ab Hamid, J.; Mohtarrudin, N.; Osman, M.; Andi Asri, A.A.; Wan Hassan, W.H.; Aziz, R. 2012: Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 and 2 as potential biomarkers for gestational hypertension Singapore Medical Journal 53(10): 681-683
Zernicke, R.F.; Wohl, G.R.; Greenwald, R.A.; Moak, S.A.; Leng, W.; Golub, L.M. 1997: Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis Journal of Rheumatology 24(7): 1324-1331
Wang, H.; Tan, L.; Liu, J.; Li, Q.; Pan, Y.; Zhong, M. 2014: Effect of smokers'sera on Porphyromonas gingivalis internalizing KB cells and the expression of matrix metalloproteinase-1, -9 and tissue inhibitor of metalloproteinase-1 Zhonghua Kou Qiang Yi Xue Za Zhi 49(1): 15-20
Haslinger, B.; Mandl-Weber, S.; Sitter, T. 2000: Thrombin suppresses matrix metalloproteinase 2 activity and increases tissue inhibitor of metalloproteinase 1 synthesis in cultured human peritoneal mesothelial cells Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(6): 778-783
Vairaktaris, E.; Serefoglou, Z.; Yapijakis, C.; Vylliotis, A.; Nkenke, E.; Derka, S.; Vassiliou, S.; Avgoustidis, D.; Neukam, F.W.; Patsouris, E. 2007: High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer Anticancer Research 27(4b): 2493-2498
Shao, C.-F.; Chang, X.-L.; Wu, Q.-E.; Ban, T.-T.; Jiang, N.; Yao, X.-M.; Zhou, Z.-J. 2008: Influence of pyrrolidine dithiocarbamate (PDTC) on expression of transforming growth factor beta(1), matrix metalloproteinase-2 and tissue inhibitor-1 of metalloproteinase in rats with pulmonary damage induced by paraquat Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 26(10): 577-582
Vasala, K.; Pääkko, P.; Turpeenniemi-Hujanen, T. 2008: Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis Anticancer Research 28(3b): 1757-1761
Ohnishi, Y.; Tajima, S.; Ishibashi, A. 2001: Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells European Journal of Dermatology: Ejd 11(5): 420-423
Moser, P.L.; Hefler, L.; Tempfer, C.; Neunteufel, W.; Kieback, D.G.; Gitsch, G. 1999: Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer Anticancer Research 19(3b): 2365-2367
Shibata, K.; Kikkawa, F.; Nawa, A.; Thant, A.A.; Naruse, K.; Mizutani, S.; Hamaguchi, M. 1998: Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells Cancer Research 58(5): 900-903
Gach, K.; Wyrebska, A.; Szemraj, J.; Janecka, A. 2012: The influence of opioid peptides on matrix metalloproteinase-9 and urokinase plasminogen activator expression in three cancer cell lines Molekuliarnaia Biologiia 46(6): 894-899
Matsuoka, T.; Yashiro, M.; Sawada, T.; Ishikawa, T.; Ohira, M.; Hirakawa, K.; Chung, Y.S. 2001: Effect of a matrix metalloproteinase inhibitor on a lymph node metastatic model of gastric cancer cells passaged by orthotopic implantation Journal of Experimental and Clinical Cancer Research: Cr 20(2): 213-218
Thiéfin, Gérard.; Dupont, Aélie.; Guillou, P-José.; Vitry, F.; Bouche, O.; Yaziji, N.; Lagarde, Séphanie.; Maquart, Fçois-Xavier.; Palot, J-Pierre.; Hornebeck, W.; Diebold, M-Danièle. 2007: Beneficial influence of microsatellite instability on gelatinase-tissue inhibitors of metalloproteinase balance in colorectal cancer Anticancer Research 27(1b): 583-588
Ajisaka, H.; Fushida, S.; Yonemura, Y.; Miwa, K. 2001: Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer Hepato-Gastroenterology 48(42): 1788-1792
Jin, M. 2001: Mechanism of expression of matrix metalloproteinase-23 (MMP-23) in rat ovary Hokkaido Journal of Medical Science 76(5): 341-348